Conditions: Choroideremia; X-Linked Retinitis Pigmentosa
Interventions: Genetic: BIIB111; Genetic: BIIB112
Sponsor: NightstaRx Ltd, a Biogen Company
Enrolling by invitation
This is a companion discussion topic for the original entry at https://clinicaltrials.gov/ct2/show/NCT03584165?recrs=abf&cond=Choroideremia&lupd_s=04%2F22%2F2022&lupd_d=14
